Transpl Int. 2021 Jun 3. doi: 10.1111/tri.13932. Online ahead of print.
ABSTRACT
BACKGROUND: Hypomagnesemia is common in kidney transplant recipients (KTRs). We sought to explore the relationship between Mg and outcomes in KTRs, which may be associated with mortality and thus, may be a potential intervention target to improve outcomes.
METHODS: We followed KTRs performed between 01/2000 and 6/2016 at a large US transplant center from 6 months post-transplant to graft failure, death, or loss to follow-up. Using Mg as a time-dependent variable, associations between Mg and outcomes any time after 6-months post-transplant were evaluated.
RESULTS: 3,680 KTRs with 50,413 Mg measurements met inclusion criteria. 657 deaths occurred over a median follow-up of 5.1 years. Compared to Mg of 1.5-1.8 mg/dL, both lower (HR 1.17, 95% Confidence interval (CI): 1.07-1.28) and higher (HR 1.16, 95% CI: 1.09-1.23) Mg levels were associated with greater risk of mortality. Similar U-shaped associations were observed for Mg and cardiovascular disease-related mortality (HR for Mg ≤1.5 mg/dL: 1.31; CI: 1.03-1.68) and infection-related mortality (HR for Mg ≤1.5 mg/dL: 1.28; CI: 1.09-1.51), although relationships for Mg >1.8 mg/dL were not statistically significant.
CONCLUSIONS: Mg exhibits a U-shaped association with mortality in KTRs, with levels between 1.5-1.8 mg/dL associated with the lowest risk.
PMID:34081803 | DOI:10.1111/tri.13932
